Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Unicycive Therapeutics Inc (NQ: UNCY )

0.5020 +0.0120 (+2.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Unicycive Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Where Unicycive Therapeutics Stands With Analysts
Via Benzinga
Analyst Expectations for Unicycive Therapeutics's Future
Via Benzinga
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week! 
Via InvestorPlace
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million... 
Via Benzinga
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
The 7 Most Undervalued Penny Stocks to Buy in October 2023
Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well. 
Via InvestorPlace
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
Appointment adds decades of drug development experience from a seasoned executive 
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate 
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.